未披露的私人方的投资将用于扩大其技术开发和产品供应。
新加坡初创公司为 DNA 健康解决方案获得 $550k
Date:
About
FigureAsia (ISSN: 3005-3978) is a premier international magazine dedicated to in-depth coverage of Asia. It offers authoritative analysis and reportage across critical domains, including politics, economics, society, culture, and technology. FigureAsia serves as a distinguished platform, delivering nuanced insights and comprehensive perspectives to an informed Asian readership, with a focus on both regional dynamics and global trends.
Magazine
News
Japan's Kaneka Pharmaceuticals acquires Israeli medical company for US$100 million
Peregrine Ventures backed the deal, which targets combined sales...
GCash reportedly selects banks for IPO in second half of 2025
The company has reportedly selected JPMorgan Chase & Co.,...
China Country Garden plans to restructure US$10.3 billion in overseas debt
Indebted Chinese real estate developer Country Garden proposed...
Subscribe
© 2024 FigureAsia Publishing Group Limited All Rights Reserved.
Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices
FigureAsia may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
ISSN: 3005-3978 is the property of FigureAsia. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.